Compare Abbott India with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PFIZER - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PFIZER ABBOTT INDIA/
PFIZER
 
P/E (TTM) x 47.8 33.4 143.0% View Chart
P/BV x 13.7 5.6 244.2% View Chart
Dividend Yield % 0.5 0.6 82.9%  

Financials

 ABBOTT INDIA   PFIZER
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
PFIZER
Mar-18
ABBOTT INDIA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs6,1102,365 258.4%   
Low Rs3,9961,625 245.9%   
Sales per share (Unadj.) Rs1,552.2430.3 360.8%  
Earnings per share (Unadj.) Rs188.878.7 239.9%  
Cash flow per share (Unadj.) Rs196.493.2 210.8%  
Dividends per share (Unadj.) Rs55.0020.00 275.0%  
Dividend yield (eoy) %1.11.0 108.6%  
Book value per share (Unadj.) Rs796.6586.5 135.8%  
Shares outstanding (eoy) m21.2545.75 46.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.34.6 70.2%   
Avg P/E ratio x26.825.3 105.6%  
P/CF ratio (eoy) x25.721.4 120.2%  
Price / Book Value ratio x6.33.4 186.5%  
Dividend payout %29.125.4 114.6%   
Avg Mkt Cap Rs m107,37691,271 117.6%   
No. of employees `0003.32.6 126.3%   
Total wages/salary Rs m3,9373,143 125.3%   
Avg. sales/employee Rs Th9,929.37,484.8 132.7%   
Avg. wages/employee Rs Th1,185.11,195.0 99.2%   
Avg. net profit/employee Rs Th1,207.71,369.1 88.2%   
INCOME DATA
Net Sales Rs m32,98519,685 167.6%  
Other income Rs m1,1701,143 102.4%   
Total revenues Rs m34,15520,828 164.0%   
Gross profit Rs m5,2455,003 104.8%  
Depreciation Rs m162663 24.4%   
Interest Rs m384 909.5%   
Profit before tax Rs m6,2155,479 113.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2031,878 117.3%   
Profit after tax Rs m4,0123,601 111.4%  
Gross profit margin %15.925.4 62.6%  
Effective tax rate %35.434.3 103.4%   
Net profit margin %12.218.3 66.5%  
BALANCE SHEET DATA
Current assets Rs m22,65524,167 93.7%   
Current liabilities Rs m6,6819,544 70.0%   
Net working cap to sales %48.474.3 65.2%  
Current ratio x3.42.5 133.9%  
Inventory Days Days6555 117.6%  
Debtors Days Days2929 101.6%  
Net fixed assets Rs m8359,514 8.8%   
Share capital Rs m213458 46.4%   
"Free" reserves Rs m16,71526,375 63.4%   
Net worth Rs m16,92826,832 63.1%   
Long term debt Rs m025 0.0%   
Total assets Rs m24,16236,900 65.5%  
Interest coverage x163.71,305.5 12.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.40.5 255.9%   
Return on assets %16.89.8 171.6%  
Return on equity %23.713.4 176.6%  
Return on capital %36.920.4 180.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36922 1,645.3%   
Fx outflow Rs m3,8071,489 255.7%   
Net fx Rs m-3,438-1,466 234.5%   
CASH FLOW
From Operations Rs m1,5273,318 46.0%  
From Investments Rs m-2,148-2,383 90.2%  
From Financial Activity Rs m-1,024-1,104 92.8%  
Net Cashflow Rs m-1,646-169 976.6%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 63.9 117.4%  
Indian inst/Mut Fund % 7.9 7.5 105.3%  
FIIs % 0.1 4.9 2.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 23.7 72.2%  
Shareholders   18,270 85,207 21.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   GSK PHARMA  JUBILANT LIFE SCIENCES  BIOCON   STERLING BIOTECH  NATCO PHARMA  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Higher; HCL Technologies & SBI Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. Sectoral indices are trading on a mixed note with stocks in the consumer durables sector.

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Oct 23, 2019 01:29 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS